Page last updated: 2024-08-21

opipramol and Ischemic Attack, Transient

opipramol has been researched along with Ischemic Attack, Transient in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cler, JA; Contreras, PC; Iyengar, S; Lanthorn, TH; Mick, SJ; Ragan, DM; Rao, TS; Wood, PL	1

Other Studies

1 other study(ies) available for opipramol and Ischemic Attack, Transient

Article	Year
Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology, 1990, Volume: 29, Issue:12 Topics: Animals; Cerebellum; Cyclic GMP; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ligands; Male; Methamphetamine; Mice; Neurons; Opipramol; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma	1990

Article

Year

Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements.

Neuropharmacology, 1990, Volume: 29, Issue:12

Topics: Animals; Cerebellum; Cyclic GMP; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ligands; Male; Methamphetamine; Mice; Neurons; Opipramol; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma

1990